alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```
 
 
MSCI EAFE MINI INDEX - NYSE LIFFE                                    Code-244041
FUTURES ONLY POSITIONS AS OF 06/10/14                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(MSCI EAFE INDEX X $50)                              OPEN INTEREST:      109,898
COMMITMENTS
  21,391   11,683    5,834   76,455   89,152  103,680  106,669    6,218    3,229

CHANGES FROM 06/03/14 (CHANGE IN OPEN INTEREST:     -2,302)
     112   -1,279    1,168   -3,797   -2,284   -2,517   -2,395      215       93

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    19.5     10.6      5.3     69.6     81.1     94.3     97.1      5.7      2.9

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:       94)
      15        5        3       55       39       70       47
 
 
MSCI EMERGING MKTS MINI INDEX - NYSE LIFFE                           Code-244042
FUTURES ONLY POSITIONS AS OF 06/10/14                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(MSCI EAFE INDEX X $50)                              OPEN INTEREST:      321,134
COMMITMENTS
 110,455   32,662    3,815  188,515  278,570  302,785  315,047   18,349    6,087

CHANGES FROM 06/03/14 (CHANGE IN OPEN INTEREST:     21,420)
  10,132    2,588      558   13,293   19,691   23,983   22,837   -2,563   -1,417

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    34.4     10.2      1.2     58.7     86.7     94.3     98.1      5.7      1.9

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      216)
      68       32       17       89       66      166      107
```

----

Updated June 13, 2014
QIHUI HUANG, Petitioner v. Ajit Varadaraj PAI, Chairman of Federal Communications Commission, et al.

No. 19-344

Supreme Court of the United States.

February 24, 2020

The petition for rehearing is denied.
[Federal Register Volume 87, Number 116 (Thursday, June 16, 2022)]
[Notices]
[Page 36338]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-12949]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NST-1 Overflow Review.
    Date: June 29, 2022.
    Time: 4:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: William C. Benzing, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, NINDS, NIH NSC, 6001 Executive Boulevard, Suite 3204, 
MSC, 9529 Rockville, MD 20852, 301-496-0660, <a href="/cdn-cgi/l/email-protection#ff9d9a918596919888bf929e9693d1919697d1989089"><span class="__cf_email__" data-cfemail="ec8e89829685828b9bac818d8580c2828584c28b839a">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: June 10, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-12949 Filed 6-15-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2018230EN.01001201.xml

| 2.7.2018 | EN | Official Journal of the European Union | C 230/12 |
| --- | --- | --- | --- |

2.7.2018

EN

Official Journal of the European Union

C 230/12

---

Prior notification of a concentration

(Case M.8997 — Whirlpool/Elica/Elica PB India Private Limited)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 230/09)

1.

This notification concerns the following undertakings:

| — | Whirlpool Corporation (‘Whirlpool’, USA), through its subsidiary Whirlpool of India Limited, |
| --- | --- |

—

Whirlpool Corporation (‘Whirlpool’, USA), through its subsidiary Whirlpool of India Limited,

| — | Elica SpA (‘Elica’, Italy), |
| --- | --- |

—

Elica SpA (‘Elica’, Italy),

| — | Elica PB India Private Limited (‘Elica PB India’, India). |
| --- | --- |

—

Elica PB India Private Limited (‘Elica PB India’, India).

Whirlpool of India Limited acquires within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Elica PB India Private Limited, currently majority owned by Elica.

The concentration is accomplished by way of a purchase of shares.

2.

| — | Whirlpool is active in the manufacture and sale of a range of appliances for refrigeration, laundry, kitchen, air conditioning and water and air purification, |
| --- | --- |

—

Whirlpool is active in the manufacture and sale of a range of appliances for refrigeration, laundry, kitchen, air conditioning and water and air purification,

| — | Elica is active in the manufacture and sale of kitchen appliances and the sale of air treatment devices, |
| --- | --- |

—

Elica is active in the manufacture and sale of kitchen appliances and the sale of air treatment devices,

| — | Elica PB India is active in the manufacture and sale of certain kitchen appliances and the sale of a range of kitchen and related cooking devices in India. |
| --- | --- |

—

Elica PB India is active in the manufacture and sale of certain kitchen appliances and the sale of a range of kitchen and related cooking devices in India.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.8997 — Whirlpool/Elica/Elica PB India Private Limited

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| Email: COMP-MERGER-REGISTRY@ec.europa.eu |
| --- |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---
I 

113TH CONGRESS 

1ST SESSION H. R. 1136 

To amend the Hate Crime Statistics Act to include crimes against the 

homeless. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 13, 2013 

Ms. EDDIE BERNICE JOHNSON of Texas (for herself, Ms. LEE of California, 

Mr. JOHNSON of Georgia, Mr. DANNY K. DAVIS of Illinois, Ms. NORTON, 

Ms. WILSON of Florida, Mr. RANGEL, Mr. HASTINGS of Florida, Mrs. 

NAPOLITANO, Mr. GRIJALVA, Mr. LEWIS, Mr. GUTIERREZ, and Ms. LORETTA SANCHEZ of California) introduced the following bill; which was 

referred to the Committee on the Judiciary 

A BILL 

To amend the Hate Crime Statistics Act to include crimes 

against the homeless. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Violence Against the 

5 Homeless Accountability Act of 2013’’. 

6 SEC. 2. INCLUSION OF HOMELESS. 

7 Section 1(b) of the Hate Crime Statistics Act (28 

8 U.S.C. 534 note) is amended— 


smartinez on DSK6TPTVN1PROD with BILLS
2 

•HR 1136 IH

1 (1) in paragraph (1), by inserting ‘‘homeless 

2 status,’’ after ‘‘sexual orientation,’’; and 

3 (2) by adding at the end the following: 

4 ‘‘(6) As used in this subsection, the term 

5 ‘homeless status’ with respect to an individual, re6 fers to an individual who— 

7 ‘‘(A) lacks a fixed, regular, and adequate 

8 nighttime residence; or 

9 ‘‘(B) has a primary nighttime residence 

10 that is— 

11 ‘‘(i) a public or private place not de12 signed for, or ordinarily used as, a regular 

13 sleeping accommodation for human beings, 

14 including cars, parks, public spaces, aban15 doned buildings, substandard housing, bus 

16 or train stations, or similar settings; 

17 ‘‘(ii) a supervised publicly or privately 

18 operated shelter designed to provide tem19 porary living accommodations, including 

20 motels, hotels, congregate shelters, and 

21 transitional housing; or 

22 ‘‘(iii) housing of other persons in 

23 which the individual is temporarily staying 


smartinez on DSK6TPTVN1PROD with BILLS
3 

•HR 1136 IH

1 due to loss of housing, economic hardship, 

2 or a similar reason.’’. 

Æ 


smartinez on DSK6TPTVN1PROD with BILLS
RITZEN GROUP, INC., Petitioner, v. JACKSON MASONRY, LLC.

No. 18-938.

Supreme Court of the United States.

Oct. 21, 2019.

Motion of the Solicitor General for leave to participate in oral argument as *amicus curiae* and for divided argument granted.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

                    Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, Small Business: Health Informatics, June 29, 2022, 10:00 a.m. to June 29, 2022, 7:00 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the                     **Federal Register**                     on June 03, 2022, FR Doc 2022-11873, 87 FR 33799.                

This notice is being amended to change the meeting date from June 29, 2022, to June 29, 2022—June 30, 2022. The meeting is closed to the public.

      ( print page 35986)    
Dated: June 8, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-12799 Filed 6-13-22; 8:45 am]

BILLING CODE 4140-01-P
xml version="1.0" encoding="UTF-8"?


C\_2018208EN.01001201.xml


| | | | |
| --- | --- | --- | --- |
| 15.6.2018 | EN | Official Journal of the European Union | C 208/12 |

---

Prior notification of a concentration

(Case M.8926 — Total/Direct Energie)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 208/10)

1.

On 7 June 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2018208EN.01001201-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | Total S.A. (‘Total’, France), |

| | |
| --- | --- |
| — | Direct Energie SA (‘Direct Energie’, France). |

Total acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Direct Energie.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   Total: international integrated energy producer and provider, active in all segments of the oil and gas industry, as well as in the renewable energy and power generation sectors,

—   Direct Energie: electric utility company operating in France and Belgium and mainly active in the production, trading and supply of electricity as well as the trading and supply of gas.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2018208EN.01001201-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.8926 — Total/Direct Energie

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| E-mail: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2018208EN.01001201-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2018208EN.01001201-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
**Exhibit31.1**

## CERTIFICATION

I, Ingrid Jackel, certify that:

1.               Ihave reviewed this quarterly report on Form 10-Q of Physicians FormulaHoldings, Inc.;

2.               Basedon my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.               Basedon my knowledge, the financial statements, and other information included inthis report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, theperiods presented in this report;

4.               Theregistrant’s other certifying officer(s) and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the registrant and have:

a.               designed suchdisclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

b.              evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

c.               disclosed in thisreport any change in the registrant’s internal control over financial reportingthat occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

5.               Theregistrant’s other certifying officer(s) and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board ofdirectors (or persons performing the equivalent functions):

a.               all significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

b.              any fraud, whetheror not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.

Date: December 20, 2006

 
| By:    | /s/ Ingrid Jackel       |   |
|--------|-------------------------|--------|
| Name:  | Ingrid Jackel           |   |
| Title: | Chief Executive Officer |   |

 

----
Exhibit 31.1





CERTIFICATION OF CHIEF EXECUTIVE OFFICER


Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002





I, Darren C. Dunckel, certify that:





(1) I have reviewed this quarterly report on Form 10-Q of Atomic Paintball Inc., (Registrant).





(2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;





(3) Based on my knowledge, the financial statements and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;





(4) The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:





(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;





(b) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and





(c) disclosed in this report any changes in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an quarterly report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and





(5) The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrants auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):





(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information ; and





(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.







Date: June 30, 2014








By:
/s/ Darren C. DunckelDarren C. DunckelChief Executive Officer, Principal Financial and Accounting Officer
xml version="1.0" encoding="UTF-8"?


C\_2018258EN.01001001.xml


| | | | |
| --- | --- | --- | --- |
| 23.7.2018 | EN | Official Journal of the European Union | C 258/10 |

---

Prior notification of a concentration

(Case M.8908 — AXA/XL Group)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 258/09)

1.

On 12 July 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2018258EN.01001001-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | AXA SA (‘AXA’) (France), |

| | |
| --- | --- |
| — | XL Group Ltd. (‘XL Group’) (Bermuda). |

AXA acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of XL Group.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

| | |
| --- | --- |
| — | AXA is the holding company of the AXA Group, a worldwide player in insurance and asset management, |

| | |
| --- | --- |
| — | XL Group is a global insurance and reinsurance company providing property, casualty and specialty products. |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2018258EN.01001001-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.8908 — AXA/XL Group

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| E-mail: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2018258EN.01001001-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2018258EN.01001001-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
Ronald Detro WINDER, Petitioner v. UNITED STATES

No. 19-6308

Supreme Court of the United States.

November 25, 2019

*560Petition for writ of certiorari to the United States Court of Appeals for the Tenth Circuit denied.